Results for Review Voucher Program

Add to feed Create your own feed

Latest

A6: Congress established the Rare Pediatric Disease PriorityReview Voucher Program to stimulate drug development for rare pediatric diseases. FDA has granted more than 200 rare pediatric disease designations for over 100 different rare pediatric diseases. #NIHchat 

#FDA updates draft guidance on rare pediatric disease priority review voucher program -

Has the priority review voucher program expanded the pipeline of rare #pediatric  disease drugs?

Has the priority review voucher program expanded the pipeline of rare #pediatric  disease drugs?

Has the priority review voucher program expanded the pipeline of rare #pediatric  disease drugs?

Rare pediatric PRV program not linked to uptick in new drugs starting trials, study finds: The rare pediatric priority review voucher (PRV) program was not found to be associated with an increase in the number or rate of new rare pediatric disease drugs…

After a sluggish start following the creation of the priority review voucher program for neglected tropical diseases in 2007, recently the issuance of vouchers in exchange for neglected disease drug approvals has picked up considerably by

tweet picture

FDA adds four tropical diseases to priority review voucher program to encourage drug development in areas of unmet need

FDA adds four tropical diseases to Priority Review voucher program: Compounds for four additional tropical diseases are now eligible to receive Priority Review vouchers upon FDA approval. FDA expanded its list of diseases eligible for the program on…

A5: 21st Century Cures Act reauthorized the Rare Pediatric Disease PriorityReview Voucher Program through Sept 30, 2020 #NIHChat 

Loading
Loading

Most relevant

#NORD met w @US_FDA  today abt implementation of #RareDisease  Pediatric Priority Review Voucher Program, an important program 4 community

A5: 21st CC Act reauthorized the Rare Pediatric Disease PriorityReview Voucher Program through Sept 30, 2020. #NIHChat 

As politicians debate the priority review voucher program, the #FDA  is rooting for its demise

To address #Zika  I cosponsored bill to add Zika to FDA's Review Voucher Program'>Priority Review Voucher Program + voted 4 $1.1 billion in funding 2 fight Zika 2/

Congress is trying to fix the huge loopholes in the priority review voucher program for needed drugs. Is it enough?

That priority review voucher program? The FDA hates it. by @JohnCFierce 

Sens Harkin & Alexander to intro a bill adding #Ebola  to tropical diseases under FDA priority review voucher program to incentivize drug dev

Loading
Loading